Valuation: Supergenics

Market Cap 29.11M 7.17M 6.42M 5.91M 5.36M 10.02M 683M 10.22M 70.64M 28.15M 359M 26.92M 26.35M 1.13B P/E 2024
-9.45x
P/E 2025 -8.61x
Enterprise Value 32.5M 8.01M 7.17M 6.6M 5.99M 11.19M 763M 11.41M 78.87M 31.43M 401M 30.06M 29.42M 1.26B EV / Sales 2024
13.9x
EV / Sales 2025 5.78x
Free-Float
41.6%
Yield 2024 *
-
Yield 2025 -
1 year 0.25
Extreme 0.25
0.25
3 years 0.15
Extreme 0.15
0.6
5 years 0.15
Extreme 0.15
0.6
10 years 0.15
Extreme 0.15
0.6
Manager TitleAgeSince
Chief Executive Officer 48 24/04/2019
Corporate Secretary - 02/06/2022
Director TitleAgeSince
Director/Board Member 48 24/04/2019
Director/Board Member 60 24/04/2019
Director/Board Member 46 28/01/2022
Change 5-day change 1-year change 3-year change Capi.($)
+21.95%-.--%+21.95%+8.70% 7.14M
+0.34%-3.03%+37.45%+61.06% 64.14B
+0.98%+2.26%+12.91%+82.98% 55.53B
+1.75%+2.76%+12.38%+103.69% 53.03B
-1.43%-0.57%+26.10%+52.86% 45.99B
-0.48%-3.86%+17.27%+117.99% 42.45B
+0.82%-2.06%+227.09%+922.41% 40.45B
-0.26%-4.20%+10.86%+45.18% 32.25B
-2.07%+44.58%+102.84%+88.74% 34.47B
-2.72%-8.79%+22.58%-5.63% 24.23B
Average +1.89%+3.44%+49.14%+147.80% 39.25B
Weighted average by Cap. -0.07%+3.13%+49.26%+160.88%

Financials

2024 2025
Net sales 5.32M 1.31M 1.17M 1.08M 980K 1.83M 125M 1.87M 12.91M 5.15M 65.61M 4.92M 4.82M 207M 5.63M 1.39M 1.24M 1.14M 1.04M 1.94M 132M 1.98M 13.65M 5.44M 69.35M 5.2M 5.09M 219M
Net income -7.28M -1.79M -1.61M -1.48M -1.34M -2.51M -171M -2.56M -17.67M -7.04M -89.77M -6.73M -6.59M -283M -3.37M -830K -742K -683K -620K -1.16M -78.98M -1.18M -8.17M -3.26M -41.49M -3.11M -3.05M -131M
Net Debt 4.48M 1.1M 987K 909K 825K 1.54M 105M 1.57M 10.86M 4.33M 55.2M 4.14M 4.05M 174M 3.39M 837K 748K 689K 625K 1.17M 79.65M 1.19M 8.24M 3.28M 41.85M 3.14M 3.07M 132M
Projected Income Statement - Annual - Supergenics
Logo Supergenics
Supergenics Berhad is a Malaysia-based management and investment holding company. The Company operates through three segments: Integrated Turnkey Solutions, Biomedical, and Investment Holding. Its Integrated Turnkey Solutions segment is engaged in the provision of integrated turnkey solutions for the related development of cleanrooms and the provision of related maintenance services. Its Biomedical segment is engaged in the provision of administrative health care services, operating medical laboratories, and developing regenerative wellness products. The Company provides laboratory services, including storage and handling of stem cell samples. Its services include stem cells, mesenchymal stem cells (MSC), natural killer (NK) cells, exosomes, and MSC exosomes. Its subsidiaries include Supergenics Solution Sdn. Bhd., Supergenics Life Science Sdn. Bhd., Supergenics Therapeutic Sdn. Bhd., Supergenics Bio Agro Sdn. Bhd., Supergenics Stembank Sdn. Bhd., and Supergenics Global Sdn. Bhd.
Employees
-
  1. Stock Market
  2. Stocks
  3. 03033 Stock